Eli Lilly announces Phase 3 ATTAIN-2 trial results for oral GLP-1 agonist orforglipron in obesity and type 2 diabetes Read more
Novartis and BioArctic sign collaboration agreement on BrainTransporter technology for neurological drug development Read more
FOPE & PharmaState Academy advance MSME excellence with PULSE session 24 on contract management Read more
FOPE & PharmaState Academy’s PULSE Program advances excellence in self-inspection & quality audits under Revised Schedule M guidelines Read more
Industry expert calls for GST parity to support MSMEs and strengthen India’s position as the ‘Pharmacy of the World’ Read more
Dr Viranchi Shah on India Pharma Inc’s balancing act between aspirations, expectations and realities Read more